Back
Hoth Therapeutics 10K Form
Sell
39
HOTH
Hoth Therapeutics
Last Price:
0.82
Seasonality Move:
-6.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HOTH News And Ratings
See the #1 stock for the next 7 days that we like better than HOTH
HOTH Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-1.63M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.09 |
Price / Book: | 0.78 |
Profitability
EPS (TTM): | -1.32000 |
---|---|
Net Income (TTM): | $-7.51M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Hoth Therapeutics Earnings Forecast
Key Hoth Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Hoth Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | HOTH |
CUSIP: | 44148G |
Website: | hoththerapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
HOTH Technical Analysis vs Fundamental Analysis
Sell
39
Hoth Therapeutics (HOTH)
is a Sell
Is Hoth Therapeutics a Buy or a Sell?
-
Hoth Therapeutics stock is rated a Sell
The current Hoth Therapeutics [HOTH] share price is $0.81. The Score for HOTH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.